Global Market Study on Biological Drugs: North America to Witness Highest Growth By 2020
Description-
Biological
Drugs
are typically derived from living cells and are used in the
prevention and treatment of various diseases such as cancer, blood
disorders, auto-immune diseases and other medical conditions.
Biological drugs have more complex structures compared to that of
conventional drugs. These are highly sensitive and more difficult to
characterize and develop. A biological drug typically has around 250
in-process tests during manufacturing compared to around 50 tests for
a conventional drug.
The
increasing prevalence of chronic diseases and growing geriatric
population are the major drivers of the global biological drugs
market. In addition, various government associations are also
supporting the growth of the biological drugs market. Furthermore,
advancements in biomedical science hold immense potential for the
growth of the biological drugs market. However, high costs of
biological drugs and patent expiry of blockbuster drugs impede the
growth of the biological drugs market. Moreover, risks of adverse
effects associated with biologic injectable drugs are also inhibiting
the growth of the biological drugs market.
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/global-market-study-on-biological-drugs-north-america-to-witness-highest-growth-by-2020-report.html
In
terms of geography, North America dominates the global biological
drugs market. This is due to increasing use of biological drugs for
the treatment of diseases such as cancer, diabetes, and other chronic
diseases. In addition, various government associations are promoting
the usage of biological drugs in North America. For instance, in
2012, the American College of Rheumatology – an organization that
advances rheumatology through education and research – recommended
biologic agents and disease-modifying antirheumatic drugs for the
treatment of rheumatoid arthritis.
In
Europe, the biological drugs market is growing due to increasing
aging population in the region. According to a UN report, elderly
people accounted for 23.2% of the total population in Germany in
2000, and the number is expected to reach 33.2% by 2025. Aging can
lead to certain disorders such as age-related macular degeneration
and glaucoma, which require biological drugs for their effective
treatment.
Low
manufacturing costs in Asia attract biopharmaceutical companies to
invest in the region. For instance, Lonza – a Switzerland-based
biotechnology company – invested around US$ 350 Mn in Singapore and
India, in order to encourage biological activities.
This
report provides in-depth analysis and estimation of the biological
drugs market for the period 2014–2020, considering 2014 as the base
year for the calculation. In addition, data pertaining to current
market dynamics, including market drivers, restraints, trends, and
recent developments, has been provided in the report. The global
biological drugs market is categorized based on therapeutic protein,
monoclonal antibodies (mAb), and vaccines. Based on therapeutic
protein, the market segments include Enbrel, Lantus, Neulasta,
Avonex, NovoLog, Rebif, Humalog, Aranesp, Epogen, Levemir, Victoza,
Betaseron, Neupogen, and Eylea. Based on mAb, the report comprises
Humira, Remicade, Rituxan, Avastin, Herceptin, and Lucentis. The
vaccine segment is further sub-segmented into Prevnar 13, Gardasil,
Fluzone, Varivax, and Cervarix. On the basis of geography, the report
identifies and analyzes the market size and predictions for North
America, Europe, Asia, and Rest of the World (RoW).
Some
of the major players in the biological drugs market are Pfizer Inc.,
Abbott Laboratories, Novartis AG, Eli Lilly and Company,
GlaxoSmithKline plc., Bristol-Myers Squibb Company, Merck & Co.,
Inc., Amgen Inc., Baxter International Inc., and Biogen Idec. These
key market players have been profiled on the basis of attributes such
as company overview, recent developments, growth strategies,
sustainability, and financial overview.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment